CRISPR/Cas9 genome editing to treat sickle cell disease

CRISPR/Cas9 genome editing to treat sickle cell disease

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliografiska uppgifter
Huvudupphovsman: Ullah, Mohammad
Övriga upphovsmän: Islam, Farzana
Materialtyp: Lärdomsprov
Språk:English
Publicerad: Brac University 2023
Ämnen:
SCD
CRISPR/Cas9
Hematopoietic stem/progenitor cells
Fetal hemoglobin
Gene editing tools
Genetic engineering > Research
Gene therapy > Research
Biotechnology
Länkar:http://hdl.handle.net/10361/19355

Internet

http://hdl.handle.net/10361/19355

Liknande verk